Heterogeneity of immune checkpoint inhibitor-related inflammatory central nervous system adverse event reporting signals in primary and metastatic brain tumors: a pharmacovigilance study with single-cell and spatial transcriptomic contextualization - Quiz - MDSpire

Heterogeneity of immune checkpoint inhibitor-related inflammatory central nervous system adverse event reporting signals in primary and metastatic brain tumors: a pharmacovigilance study with single-cell and spatial transcriptomic contextualization

  • By

  • Junlin Song

  • Zeyu He

  • Chong Han

  • Xiaohong Hou

  • July 8, 2026

  • 0 min

Share

Original Source(s)

Heterogeneity of immune checkpoint inhibitor-related inflammatory central nervous system adverse event reporting signals in primary and metastatic brain tumors: a pharmacovigilance study with single-cell and spatial transcriptomic contextualization

  • by Junlin Song, Zeyu He, Chong Han, Xiaohong Hou

  • July 8, 2026

Related Content

Interpretable early mortality prediction in oncology ICU patients: A dual-cohort validation of a LASSO–XGBoost–SHAP framework

Head and neck squamous cell carcinoma with femoral metastasis: a case report and systematic review of current literature

CAR-T cell signaling dynamics, rational design principles and artificial intelligence for next-generation chimeric antigen receptors